[Mitoxantrone-aracytine with or without quinine in the treatment of refractory or relapsed acute leukemia].
Solary
E
E
Hématologie Clinique, CHU Le Bocage, Dijon, France.
Witz
F
F
Moreau
P
P
Quiquandon
I
I
Genne
P
P
Flesch
M
M
Saddoun
A
A
Maloisel
F
F
Pignon
B
B
Abgrall
J F
JF
D000208:Acute Disease; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D008942:Mitoxantrone / Q000008:administration & dosage; D011803:Quinine / Q000008:administration & dosage; D012008:Recurrence
D003561:Cytarabine; D011803:Quinine; D008942:Mitoxantrone
Mitoxantrone--aracytine avec ou sans quinine dans le traitement des leucémies aiguës réfractaires ou en rechute.